Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-06-13

Clinical Trial Update: Effect of Intracameral Phenylephrine/Ketorolac on Intraoperative Pain [Phase 4]

View source ↗

Summary

Phase 4 trial investigating intracameral phenylephrine/ketorolac for intraoperative pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • phenylephrine/ketorolac (phenylephrine/ketorolac)

Snippet

Sponsor: University of Florida | Conditions: Pain Reduction | Phase 4 | Status: WITHDRAWN